Template letter for getting ivermectin with medical supervision
Dear Dr _______,
I am aware that you might not have heard about ivermectin as a treatment for COVID. If you have, you might be surprised to discover that the evidence for its safety and effectiveness is overwhelming.
I am one of those laypersons who get their medical information on social networks. However, as opposed to several misguided people, I always take care to verify the trustworthiness of my sources.
This is why I'm recommending that you consult the Frontline COVID-19 Critical Care (FLCCC) Alliance, here. I also suggest that you take a look at the real-time meta-analysis of ivermectin studies at ivmmeta.com.
Moreover, you might find it interesting to read this up-to-date list of countries and regions which have adopted ivermectin and to consult the graphics continuously made by data analyst Juan Chamie to follow the consequences of adopting ivermectin in those countries and regions, here. Chamie’s most compelling findings can be found in the Epidemiologic Analyses on COVID-19 and Ivermectin section of the FLCCC website.
Finally, Satoshi Ōmura, the co-developer of ivermectin, who received the 2015 Nobel prize in Physiology or Medicine, wrote an enlightening paper covering the reasons why you might not have heard about ivermectin or might have read "no evidence" statements from health authorities and the media. Following Satoshi Ōmura's lead, Japan is taking action to implement ivermectin, see here and there.
Tess Lawrie, an expert reviewer from the Evidence-Based Medicine Consultancy Ltd, with years of experience producing meta-analyses for the WHO and the Cochrane collaboration (click “Work”, here), has first-hand experience of the processes leading up to ivermectin being ignored or misrepresented (for a discussion with another well known medical doctor, see here; for an insider's look at the assessment process in journals and health organizations, see, for example, this interview).
But I'm aware that this represents hours of work for you, and that caring for patients takes up most of your time. I'm also aware that there exist institutional pressures that may limit your ability to prescribe ivermectin according to the FLCCC Alliance's recommendations, found above.
For the reasons listed above, I am informing you that I have acquired over-the-counter ivermectin for my personal use and that I will apply FLCCC's prophylaxis or treatment protocols, depending on the situation.
I am inviting you to discuss our relationship in this context. Of course, if you decide to prescribe ivermectin off-label because you don't feel that my ivermectin is trustworthy, this will be the best possible scenario for us.
Best regards,
_______